Nomad Power Solutions (NMAD) Other Working Capital Changes (2010 - 2023)
Nomad Power Solutions (NMAD) posted Other Working Capital Changes of -$21723.0 for Q3 2023, down 232.36% on a QoQ basis from -$6536.0 in Q2 2023, and down 30.82% year-over-year from -$31401.6 in Q3 2022.
Analysis
Nomad Power Solutions (NMAD) Other Working Capital Changes (2010 - 2023) Analysis & Trends
Nomad Power Solutions has reported Other Working Capital Changes for 14 years, with the latest figure at -$21723.0 in Q3 2023.
- On a quarterly basis, Other Working Capital Changes fell 30.82% year-over-year to -$21723.0 in Q3 2023; TTM through Sep 2023 was $3883.0, a 146.97% increase from a year earlier, with the FY2022 full-year figure at $131.0, up 102.76% from the prior year.
- Other Working Capital Changes was -$21723.0 for Q3 2023 at Nomad Power Solutions, down from -$6536.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $47500.0 in Q1 2021, with the low at -$21975.0 in Q4 2021.
- Average Other Working Capital Changes over 5 years is -$72.53, with a median of -$6656.0 recorded in 2019.
- The sharpest annual moves came in 2019 and 2021: Other Working Capital Changes tumbled 7373.75% in 2019, then jumped 997.07% in 2021.
- Over 5 years, Other Working Capital Changes stood at -$8339.0 in 2019, then soared by 123.98% to $2000.0 in 2020, then tumbled by 1198.75% to -$21975.0 in 2021, then surged by 38.22% to -$13577.0 in 2022, then slumped by 60.0% to -$21723.0 in 2023.
- The last three Other Working Capital Changes figures came in at -$21723.0 (Q3 2023), -$6536.0 (Q2 2023), and $45719.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -21,723.00 |
| Sep 30, 2023 | -21,723.00 |
| Jun 30, 2023 | -6,536.00 |
| Jun 30, 2023 | -6,536.00 |
| Mar 31, 2023 | 45,719.00 |
| Mar 31, 2023 | 45,719.00 |
| Dec 31, 2022 | -13,577.00 |
| Dec 31, 2022 | -13,577.00 |
| Sep 30, 2022 | -16,605.00 |
| Sep 30, 2022 | -16,605.00 |
| Jun 30, 2022 | -11,357.00 |
| Jun 30, 2022 | -11,357.00 |
| Mar 31, 2022 | 41,670.00 |
| Mar 31, 2022 | 41,670.00 |
| Dec 31, 2021 | -21,975.00 |
| Dec 31, 2021 | -21,975.00 |
| Sep 30, 2021 | -12,647.00 |
| Sep 30, 2021 | -12,647.00 |
| Jun 30, 2021 | -17,629.00 |
| Jun 30, 2021 | -17,629.00 |